Matches in Wikidata for { <http://www.wikidata.org/entity/Q59361039> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q59361039 description "article" @default.
- Q59361039 description "artículu científicu" @default.
- Q59361039 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59361039 description "wetenschappelijk artikel" @default.
- Q59361039 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q59361039 name "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 name "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 type Item @default.
- Q59361039 label "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 label "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 prefLabel "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 prefLabel "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 P1433 Q59361039-7D7273A2-BF08-43A1-89B1-6CF87094531C @default.
- Q59361039 P1476 Q59361039-B2F83D58-19C4-4432-B0AF-38AA382BC542 @default.
- Q59361039 P2093 Q59361039-190F1DE5-3037-46F6-A578-5EECDCB0D8D2 @default.
- Q59361039 P2093 Q59361039-1AB16BCF-3E29-459D-B170-1C4CCBAC302C @default.
- Q59361039 P2093 Q59361039-6AA2DE0E-4926-4904-BCB1-04D1F63F9BD2 @default.
- Q59361039 P2093 Q59361039-829D0459-A6F5-4B3F-ABAB-3716DB4A6AB6 @default.
- Q59361039 P2093 Q59361039-D8AF66F4-6B66-458D-BA0B-CD80A38BBD68 @default.
- Q59361039 P304 Q59361039-081C99D3-16E2-4E30-9ADD-708EB1E3A2A9 @default.
- Q59361039 P31 Q59361039-4E2A8794-0CEA-48C7-908F-DD3DBF8354C5 @default.
- Q59361039 P356 Q59361039-801A4DBD-FE79-49FD-9679-FA9466633FCD @default.
- Q59361039 P407 Q59361039-81D3B47B-5295-413D-8124-9B9A575315D9 @default.
- Q59361039 P433 Q59361039-940F376B-22AA-48D5-9301-70A3F8EF6A40 @default.
- Q59361039 P478 Q59361039-5CC61F76-1864-4F2E-8B43-E8B12143B7A4 @default.
- Q59361039 P577 Q59361039-E3AD1292-C170-42A5-A498-C967D66EA882 @default.
- Q59361039 P698 Q59361039-0F4BAF39-9DD5-4BBA-A7DF-65C11ACF7A00 @default.
- Q59361039 P356 JCPH.1135 @default.
- Q59361039 P698 29746724 @default.
- Q59361039 P1433 Q7743562 @default.
- Q59361039 P1476 "Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical Practice" @default.
- Q59361039 P2093 "Benedetto Caroleo" @default.
- Q59361039 P2093 "Giovambattista De Sarro" @default.
- Q59361039 P2093 "Lidia Colangelo" @default.
- Q59361039 P2093 "Luca Gallelli" @default.
- Q59361039 P2093 "Maria Perticone" @default.
- Q59361039 P304 "1248-1253" @default.
- Q59361039 P31 Q13442814 @default.
- Q59361039 P356 "10.1002/JCPH.1135" @default.
- Q59361039 P407 Q1860 @default.
- Q59361039 P433 "10" @default.
- Q59361039 P478 "58" @default.
- Q59361039 P577 "2018-05-10T00:00:00Z" @default.
- Q59361039 P698 "29746724" @default.